| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,938.15
|
|
Change (%)
|
7.70 (0.40%)
|
|
Best Buy (RS)
|
1938(x73)
|
|
Best Sell (RS)
|
1939.15(x28)
|
|
Today's Range (RS)
|
1,915.75
-
1,948.05
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.45
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharma update on Lipitor antitrust litigation in US court |
| Sun Pharma receives favorable court ruling in Lipitor patent settlement case in US |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
| Sun Pharma gets nod for Semaglutide injection in South Africa |
| Barometers trade higher; private bank shares jump |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
25-Aug-2026 |
1917.00 |
0.70 |
| 1Month |
03-Aug-2026 |
1950.00 |
-1.00 |
| 3Month |
01-Jun-2026 |
1795.95 |
7.49 |
| 6Month |
02-Mar-2026 |
1752.70 |
10.14 |
| 1Year |
01-Sep-2025 |
1563.35 |
23.48 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.88 |
4066.76 |
| SBI BSE SENSEX ETF |
2.31 |
2843.23 |
| ICICI Pru Value Fund |
4.49 |
2740.90 |
| ICICI Pru Aggressive Hybrid Fund |
3.74 |
1961.25 |
| ICICI Pru Large Cap Fund |
2.23 |
1805.14 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Zydus Lifesciences Ltd |
1,160.15 |
-0.34 |
1,205.65 |
835.85 |
116,114.43 |
| Cipla Ltd |
1,406.00 |
-0.85 |
1,672.20 |
1,165.55 |
114,554.33 |
| Laurus Labs Ltd |
1,836.50 |
-1.26 |
1,947.90 |
822.85 |
100,498.07 |
| Lupin Ltd |
2,140.00 |
-0.47 |
2,530.00 |
1,881.80 |
98,312.16 |
| Dr Reddys Laboratories Ltd |
1,167.40 |
-0.31 |
1,414.40 |
1,080.05 |
97,741.02 |
|
|
|
|